- Home
- RLAY vs PSFE Comparison
RLAY vs PSFE Comparison
Compare RLAY & PSFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- PSFE
- Stock Information
- Founded
- RLAY 2015
- PSFE 1996
- Country
- RLAY United States
- PSFE United Kingdom
- Employees
- RLAY N/A
- PSFE N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- PSFE Business Services
- Sector
- RLAY Health Care
- PSFE Consumer Discretionary
- Exchange
- RLAY Nasdaq
- PSFE Nasdaq
- Market Cap
- RLAY 803.4M
- PSFE 765.0M
- IPO Year
- RLAY 2020
- PSFE N/A
- Fundamental
- Price
- RLAY $6.22
- PSFE $12.05
- Analyst Decision
- RLAY Strong Buy
- PSFE Sell
- Analyst Count
- RLAY 8
- PSFE 4
- Target Price
- RLAY $17.25
- PSFE $17.38
- AVG Volume (30 Days)
- RLAY 1.7M
- PSFE 250.1K
- Earning Date
- RLAY 11-05-2025
- PSFE 11-12-2025
- Dividend Yield
- RLAY N/A
- PSFE N/A
- EPS Growth
- RLAY N/A
- PSFE N/A
- EPS
- RLAY N/A
- PSFE N/A
- Revenue
- RLAY $8,355,000.00
- PSFE $1,676,391,000.00
- Revenue This Year
- RLAY $27.33
- PSFE $3.18
- Revenue Next Year
- RLAY $7.40
- PSFE $7.05
- P/E Ratio
- RLAY N/A
- PSFE N/A
- Revenue Growth
- RLAY N/A
- PSFE 0.47
- 52 Week Low
- RLAY $1.78
- PSFE $10.63
- 52 Week High
- RLAY $7.07
- PSFE $26.25
- Technical
- Relative Strength Index (RSI)
- RLAY 71.34
- PSFE 36.36
- Support Level
- RLAY $5.47
- PSFE $11.58
- Resistance Level
- RLAY $7.00
- PSFE $12.61
- Average True Range (ATR)
- RLAY 0.37
- PSFE 0.44
- MACD
- RLAY 0.11
- PSFE -0.13
- Stochastic Oscillator
- RLAY 70.90
- PSFE 23.15
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About PSFE Paysafe Limited
Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.